top of page

A Girls How To Guide

Search

Pfizer Reports Second-Quarter 2017 Results

Pfizer Reports Second-Quarter 2017 Results

Pfizer Reports Second-Quarter 2017 Results

Safi Bello

Aug 2, 20171 min read

Disease Hunters Enlarge the Enemy to Get a Better Look

Disease Hunters Enlarge the Enemy to Get a Better Look

Disease Hunters Enlarge the Enemy to Get a Better Look

Safi Bello

Aug 1, 20171 min read

FDA approves new targeted treatment for relapsed or refractory acute myeloid leukemia

FDA approves new targeted treatment for relapsed or refractory acute myeloid leukemia

FDA approves new targeted treatment for relapsed or refractory acute myeloid leukemia

Safi Bello

Aug 1, 20171 min read

Trump urged to declare national emergency over US opioid epidemic

Trump urged to declare national emergency over US opioid epidemic

Trump urged to declare national emergency over US opioid epidemic

Safi Bello

Aug 1, 20171 min read

Bristol-Myers, Pfizer come up victorious in 20 more Eliquis bleeding cases

Bristol-Myers, Pfizer come up victorious in 20 more Eliquis bleeding cases

Bristol-Myers, Pfizer come up victorious in 20 more Eliquis bleeding cases

Safi Bello

Jul 31, 20171 min read

AbbVie scores surprisingly good Q2 results but pipeline worries persist

AbbVie scores surprisingly good Q2 results but pipeline worries persist

AbbVie scores surprisingly good Q2 results but pipeline worries persist

Safi Bello

Jul 28, 20171 min read

Still reeling from cyberattack, Merck warns some drug supplies may be delayed

Still reeling from cyberattack, Merck warns some drug supplies may be delayed

Still reeling from cyberattack, Merck warns some drug supplies may be delayed

Safi Bello

Jul 28, 20171 min read

FDA aims to cut nicotine in cigarettes, ease e-cigarette rules

FDA aims to cut nicotine in cigarettes, ease e-cigarette rules

FDA aims to cut nicotine in cigarettes, ease e-cigarette rules

Safi Bello

Jul 28, 20171 min read

GlaxoSmithKline's talk of leaving rare diseases—amid slow Strimvelis sales—highlights challenges

GlaxoSmithKline's talk of leaving rare diseases—amid slow Strimvelis sales—highlights challenges

GlaxoSmithKline's talk of leaving rare diseases—amid slow Strimvelis sales—highlights challenges

Safi Bello

Jul 27, 20171 min read

AstraZeneca lung cancer immunotherapy trial failure sends shares plunging

AstraZeneca lung cancer immunotherapy trial failure sends shares plunging

AstraZeneca lung cancer immunotherapy trial failure sends shares plunging

Safi Bello

Jul 27, 20171 min read

Follow Us

bottom of page